Barr Has No Plan B Plans For Broad DTC Campaign
This article was originally published in The Tan Sheet
Barr is running an advertising campaign in college newspapers for its Plan B emergency contraceptive while the company awaits FDA's decision on an OTC switch of the drug
You may also be interested in...
FDA appears to be ready to create a third class of drugs
Advertising for Barr Labs' Plan B emergency contraceptive will center on the drug regimen as a "second chance" for users to avoid pregnancy, CEO Bruce Downey told shareholders on Oct. 28
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC